Turkey · Delayed Price · Currency is TRY Deva Holding A.S. Company Description
Deva Holding A.S. manufactures, markets, and sells pharmaceutical products in Turkey.
The company offers antineoplastic and immunomodulating agents; dermatological products; sysyemic hormanal preparations; anti-infective and antiparasitic products for systemic use; food supplements; and electrolyte solutions.
It also provides products in the areas of urogenital system and sex hormones, blood and blood forming organs, cardiovascular system, musculoskeletal system, nervous system, alimentary tract and metabolism, respiratory system, urinary systems, connective tissue, and sensory organs.
In addition, the company offers various products in sterile and non-sterile forms, including liquids, semi-solids, solids, cephalosporins, penicillin, hormone and inhalation products, solid and liquid oncology, animal health products, active pharmaceutical ingredients, ampoules, liquid and lyophilized vials, eye drops, medical ampoules for sterile injectable products, and cologne.
It also exports its products to approximately 60 countries. The company was incorporated in 1958 and is based in Istanbul, Turkey.
Deva Holding A.S. is a subsidiary of Eastpharma S.à R.L.
| Country | Turkey |
| Founded | 1958 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 3,063 |
| CEO | Philipp Haas |
Contact Details
Address: Halkali Merkez Mah. Istanbul, 34303 Turkey | |
| Phone | 90 212 692 92 92 |
| Website | deva.com.tr |
Stock Details
| Ticker Symbol | DEVA |
| Exchange | Istanbul Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | TRY |
| ISIN Number | TRADEVAW91E2 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Philipp Anthony Haas | Chairman and Chief Executive Officer |
| Mesut Çetin | Chief Financial Officer |
| Riza Yildiz | Financial Reporting and Accounting Director |
| Tijen Kavlak | Marketing and Communication Director |
| Gülseren Mahmutoglu | Deputy Manager of Treasury and Shareholder Relations |
| Dogan Varinlioglu | Deputy General Manager of Turkey and International Markets |
| Hartwig Andreas Steckel | R&D Director |